Withdrawn heart drug trial aimed to slow deadly protein buildup
NCT ID NCT04843020
Summary
This study aimed to see if a drug called ION-682884 could slow or stop the progression of a serious heart condition called TTR amyloid cardiomyopathy. The drug was designed to reduce the production of a harmful protein that builds up in the heart. The trial was only for a small group of older patients (65-85 years) who had already completed a previous 2-year study with a similar drug. However, this trial was withdrawn and did not enroll any participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.